We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GE:NYSEGE Aerospace Analysis

Data as of 2026-08-22 - not real-time

$348.37

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At $348.37, GE Aerospace shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has lost 3.0% over the past 30 days. RSI sits at 42.7, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $343.56 and resistance around $388.84.
Multiples put this in overvalued territory: 41.1 times earnings against the sector's 29.9. Consensus targets land 16.2% above where the shares trade now. Revenue is growing at 21.1% on a 17.7% profit margin. The 0.54% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 32.7%, a beta of 1.25 and a maximum drawdown of 21.0%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

GE Aerospace keeps beating estimates, raising guidance, and sitting on a $210 billion backlog, yet the stock may...GE Aerospace is performing very well as a business, and perhaps even better as a stock.14dGE Aerospace Is At Risk Of OverheatingGE Aerospace continues to deliver robust revenue, profit, and cash flow...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 319.65
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 41.1 versus sector average of 29.9
  • Trading above the 200-day average of 319.65

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 41.1 versus sector average of 29.9
  • Analyst targets imply +16.2% versus the current price
  • Profit margin of 17.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth21.10%
Profit Margin17.72%
P/E Ratio41.1
ROE48.23%
ROA5.07%
Debt/Equity113.22
P/B Ratio20.5
Op. Cash Flow$9.8B
Free Cash Flow$6.6B
Industry P/E29.9

Technical Analysis

TrendBullish
RSI42.7
Support$343.56
Resistance$388.84
MA 20$364.29
MA 50$359.77
MA 200$319.65
MACDBearish
VolumeIncreasing
Fear & Greed Index94.41

Valuation

Fair Value$181.88
Target Price$404.90
Upside/Downside16.23%
GradeOvervalued
TypeGrowth
Dividend Yield0.54%

Risk Assessment

Beta1.25
Volatility32.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.